Portfolio Holdings Detail for ISIN IE00B53SZB19
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 63

Stock Name / Fund	iShares NASDAQ 100 UCITS ETF USD (Acc)
Issuer	Blackrock
ETF Ticker	CNX1(GBX) LSE
ETF Ticker	SXRV(EUR) F
ETF Ticker	CNDX.AS(EUR) CXE
ETF Ticker	CNDX.LS(USD) CXE
ETF Ticker	CNX1.LS(GBX) CXE
ETF Ticker	CSNDX.MI(EUR) CXE
ETF Ticker	CSNDXz(USD) CXE
ETF Ticker	SXRV.DE(EUR) CXE
ETF Ticker	CSNDX(EUR) ETF Plus
ETF Ticker	CNDX(EUR) Euronext Amsterdam
ETF Ticker	CNX1.L(GBP) LSE

Holdings detail for VRTX

Show aggregate VRTX holdings

News associated with VRTX

ProShares Ultra QQQ Experiences Big Inflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra QQQ (Symbol: QLD) where we have detected an approximate $392.3 million dollar inflow -- that's a 7.2% increase week over week in outs - 2025-04-15 15:02:19

Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce

Yo-yos are fun for kids. But yo-yo stock markets aren't so fun for grown-up investors. And unfortunately, there's been a lot more down "yo" recently than up "yo." - 2025-04-15 08:45:00

Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades

"May you live in interesting times." - 2025-04-12 08:48:00

We're About to Find Out the Answer to Warren Buffett's Pointed Question About Trump's Tariffs. Here Are 3 Stocks to Buy Depending on What That Answer Is.

Contrary to what you might read on social media, Warren Buffett isn't a fan of tariffs. Berkshire Hathaway even recently took the unusual step of issuing a press release refuting social media claims that Buffett applauded President Trump's economic policies. - 2025-04-10 07:52:00

Arrowstreet Capital Limited Partnership Takes $3.73 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Arrowstreet Capital Limited Partnership purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,265 shares of the pharmaceutical company’s stock, valued at approximately $3,731,000. Several other […] - 2025-04-09 08:14:56

TQQQ, NFLX, GOOG, VRTX: Large Inflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares UltraPro QQQ (Symbol: TQQQ) where we have detected an approximate $480.8 million dollar inflow -- that's a 3.4% increase week over week in - 2025-04-07 15:35:24

Validea Detailed Fundamental Analysis - VRTX

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks - 2025-04-07 12:38:05

2 Stocks to Buy if You're Worried About a Recession

Is a recession coming? Our economic outlook seems increasingly gloomy due to President Trump's trade policies. Though things might not go that far, it's still worth planning ahead. - 2025-04-07 09:24:00

Vertex Pharmaceuticals (NASDAQ:VRTX) Given New $567.00 Price Target at Bank of America

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective increased by Bank of America from $555.00 to $567.00 in a research note issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the pharmaceutical company’s stock. Bank of America‘s price objective would indicate a potential upside of 16.97% from the company’s […] - 2025-04-02 06:00:47

Validea Detailed Fundamental Analysis - VRTX

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks - 2025-03-28 14:31:33

Rattled by the Stock Market Sell-Off? These 3 Stocks Outperformed the S&P 500 During the Great Recession

The economy has been on shaky ground for a while, and President Trump's tariffs and trade wars could finally send it into a recession. That's a big concern for the market these days as consumers have been keeping discretionary spending to a minimum as high costs have created many - 2025-03-28 10:30:00

Notable ETF Outflow Detected - XLV, DHR, VRTX, SYK

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $702.0 million dollar outflow -- that's a 1.8% decrease - 2025-03-27 16:02:51

Brokerages Set Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) PT at $506.70

Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-six research firms that are covering the firm, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a hold recommendation, fifteen have assigned a buy recommendation and one has given a strong […] - 2025-03-20 06:04:53

Notable ETF Outflow Detected - IVW, VRTX, FI, GEV

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares S&P 500 Growth ETF (Symbol: IVW) where we have detected an approximate $392.2 million dollar outflow -- that's a 0.8% decrease week over - 2025-03-19 15:41:35

3 Unstoppable Stocks You Can Buy Now Without Any Hesitation

Are you reluctant to invest in stocks right now? That's understandable. Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility. - 2025-03-17 10:47:00

AlphaQuest LLC Sells 2,767 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

AlphaQuest LLC trimmed its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 84.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 517 shares of the pharmaceutical company’s stock after selling 2,767 shares during the period. AlphaQuest LLC’s holdings in Vertex Pharmaceuticals were worth $208,000 as […] - 2025-03-17 08:02:56

3 Stocks With Ironclad Balance Sheets for Long-Term Stability

Although sometimes overshadowed by the all-important income statement, the balance sheet can offer essential insights into a company's financial health. It revolves around the balance between a company’s assets and liabilities. It helps assess factors important to overall financ - 2025-03-13 11:22:00

Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Buy at StockNews.com

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Tuesday. A number of other equities analysts have also weighed in on VRTX. HC Wainwright reiterated a “buy” rating and issued a $550.00 price target on shares of […] - 2025-03-13 06:26:55

Rep. Jefferson Shreve Purchases Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Representative Jefferson Shreve (R-Indiana) recently bought shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). In a filing disclosed on March 09th, the Representative disclosed that they had bought between $15,001 and $50,000 in Vertex Pharmaceuticals stock on February 24th. The trade occurred in the Representative’s “CRT – STANDARD UNIT TRUST” account. Representative Jefferson Shreve also recently made […] - 2025-03-12 06:04:59

IVW, AXP, FI, VRTX: ETF Outflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares S&P 500 Growth ETF (Symbol: IVW) where we have detected an approximate $306.8 million dollar outflow -- that's a 0.6% decrease week over - 2025-03-11 15:28:55

Company News for Mar 11, 2025

Companies in The News Are: VRTX, TSLA, NVDA, COIN - 2025-03-11 13:22:00

Nasdaq Correction: The 2 Smartest Stocks to Buy and Hold Forever

When you're on an airplane, the pilot or a flight attendant will typically announce over the loudspeaker to "buckle your seatbelt" when the air is turbulent. That could be good advice for investors right now, too. - 2025-03-11 09:31:00

Where Will Vertex Pharmaceuticals Be in 10 Years?

The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its first cystic fibrosis (CF) drug -- Kalydeco -- back in 2012 and has since gained the regulatory nod for four more and become the global leader in the CF market - 2025-03-11 08:25:00

5 Top Stocks to Buy in March

2025 has gotten off to a choppy start as some of the most valuable U.S.-based companies are dragging down the major stock market indexes. But getting caught up in short-term market movements is a mistake. - 2025-03-04 11:15:00

XLV, SYK, DHR, VRTX: Large Outflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $434.3 million dollar outflow -- that's a 1.1% decrease - 2025-02-21 16:22:43

Vertex Pharmaceuticals (NASDAQ:VRTX) Lowered to Hold Rating by StockNews.com

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Wednesday. VRTX has been the subject of a number of other reports. Scotiabank raised their price objective on Vertex Pharmaceuticals from $433.00 to $450.00 and gave the stock […] - 2025-02-21 06:55:07

Are Wall Street Analysts Predicting Vertex Pharmaceuticals Stock Will Climb or Sink?

Vertex Pharmaceuticals has lagged behind the broader market over the past year, and Wall Street analysts are cautiously optimistic about the stock’s future. - 2025-02-20 14:51:41

Blue Trust Inc. Sells 2,077 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Blue Trust Inc. lowered its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 76.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 634 shares of the pharmaceutical company’s stock after selling 2,077 shares during the period. Blue […] - 2025-02-19 09:02:04

IUSG, ANET, VRTX, PH: ETF Outflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P U.S. Growth ETF (Symbol: IUSG) where we have detected an approximate $324.0 million dollar outflow -- that's a 1.5% decrease we - 2025-02-13 15:47:21

Vertex Pharmaceuticals (NASDAQ:VRTX) Given “Hold” Rating at Needham & Company LLC

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “hold” rating restated by research analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports. Other equities analysts have also issued reports about the stock. Citigroup started coverage on shares of Vertex Pharmaceuticals in a research report on Thursday, November 14th. […] - 2025-02-13 09:32:55

iShares NASDAQ 100 UCITS ETF USD (Acc) VRTX holdings

Date	Number of VRTX Shares Held	Base Market Value of VRTX Shares	Local Market Value of VRTX Shares	Change in VRTX Shares Held	Change in VRTX Base Value	Current Price per VRTX Share Held	Previous Price per VRTX Share Held
2025-04-17 (Thursday)	293,289	USD 143,447,650	USD 143,447,650
2025-04-16 (Wednesday)	293,289	USD 142,506,192	USD 142,506,192	236	USD -4,163,904	USD 485.89	USD 500.49
2025-04-15 (Tuesday)	293,053	USD 146,670,096	USD 146,670,096	590	USD 1,658,167	USD 500.49	USD 495.83
2025-04-14 (Monday)	292,463	USD 145,011,929	USD 145,011,929	1,416	USD 4,081,151	USD 495.83	USD 484.22
2025-04-11 (Friday)	291,047	USD 140,930,778	USD 140,930,778	472	USD 2,765,271	USD 484.22	USD 475.49
2025-04-10 (Thursday)	290,575	USD 138,165,507	USD 138,165,507	0	USD -1,978,816	USD 475.49	USD 482.3
2025-04-09 (Wednesday)	290,575	USD 140,144,323	USD 140,144,323	1,298	USD 3,498,547	USD 482.3	USD 472.37
2025-04-08 (Tuesday)	289,277	USD 136,645,776	USD 136,645,776	2,360	USD 486,444	USD 472.37	USD 474.56
2025-04-07 (Monday)	286,917	USD 136,159,332	USD 136,159,332	0	USD -17,215	USD 474.56	USD 474.62
2025-04-04 (Friday)	286,917	USD 136,176,547	USD 136,176,547	-1,534	USD -3,286,627	USD 474.62	USD 483.49
2025-04-02 (Wednesday)	288,451	USD 139,463,174	USD 139,463,174	-118	USD -417,763	USD 483.49	USD 484.74
2025-04-01 (Tuesday)	288,569	USD 139,880,937	USD 139,880,937	-118	USD -80,294	USD 484.74	USD 484.82
2025-03-31 (Monday)	288,687	USD 139,961,231	USD 139,961,231	-814	USD -2,673,017	USD 484.82	USD 492.69
2025-03-28 (Friday)	289,501	USD 142,634,248	USD 142,634,248	0	USD -2,854,480	USD 492.69	USD 502.55
2025-03-27 (Thursday)	289,501	USD 145,488,728	USD 145,488,728	0	USD 657,168	USD 502.55	USD 500.28
2025-03-26 (Wednesday)	289,501	USD 144,831,560	USD 144,831,560	1,050	USD -2,001,537	USD 500.28	USD 509.04
2025-03-25 (Tuesday)	288,451	USD 146,833,097	USD 146,833,097	1,292	USD -117,650	USD 509.04	USD 511.74
2025-03-24 (Monday)	287,159	USD 146,950,747	USD 146,950,747	354	USD 2,630,471	USD 511.74	USD 503.2
2025-03-21 (Friday)	286,805	USD 144,320,276	USD 144,320,276	118	USD -1,941,698	USD 503.2	USD 510.18
2025-03-20 (Thursday)	286,687	USD 146,261,974	USD 146,261,974	236	USD -549,893	USD 510.18	USD 512.52
2025-03-19 (Wednesday)	286,451	USD 146,811,867	USD 146,811,867	926	USD 557,396	USD 512.52	USD 512.23
2025-03-18 (Tuesday)	285,525	USD 146,254,471	USD 146,254,471	236	USD -315,606	USD 512.23	USD 513.76
2025-03-17 (Monday)	285,289	USD 146,570,077	USD 146,570,077	-354	USD 2,386,060	USD 513.76	USD 504.77
2025-03-14 (Friday)	285,643	USD 144,184,017	USD 144,184,017	590	USD 825,162	USD 504.77	USD 502.92
2025-03-13 (Thursday)	285,053	USD 143,358,855	USD 143,358,855	236	USD 2,254,817	USD 502.92	USD 495.42
2025-03-12 (Wednesday)	284,817	USD 141,104,038	USD 141,104,038	0	USD 2,016,504	USD 495.42	USD 488.34
2025-03-11 (Tuesday)	284,817	USD 139,087,534	USD 139,087,534	-664	USD -3,655,821	USD 488.34	USD 500.01
2025-03-10 (Monday)	285,481	USD 142,743,355	USD 142,743,355	-590	USD 3,057,746	USD 500.01	USD 488.29
2025-03-07 (Friday)	286,071	USD 139,685,609	USD 139,685,609	0	USD 735,203	USD 488.29	USD 485.72
2025-03-06 (Thursday)	286,071	USD 138,950,406	USD 138,950,406	-590	USD -1,983,608	USD 485.72	USD 491.64
2025-03-05 (Wednesday)	286,661	USD 140,934,014	USD 140,934,014	-236	USD 1,438,955	USD 491.64	USD 486.22
2025-03-04 (Tuesday)	286,897	USD 139,495,059	USD 139,495,059	-1,062	USD 321,595	USD 486.22	USD 483.31
2025-03-03 (Monday)	287,959	USD 139,173,464	USD 139,173,464	-557	USD 746,372	USD 483.31	USD 479.79
2025-02-28 (Friday)	288,516	USD 138,427,092	USD 138,427,092	-343	USD 1,363,496	USD 479.79	USD 474.5
2025-02-27 (Thursday)	288,859	USD 137,063,596	USD 137,063,596	0	USD -1,328,751	USD 474.5	USD 479.1
2025-02-26 (Wednesday)	288,859	USD 138,392,347	USD 138,392,347	0	USD -361,074	USD 479.1	USD 480.35
2025-02-25 (Tuesday)	288,859	USD 138,753,421	USD 138,753,421	-472	USD -602,855	USD 480.35	USD 481.65
2025-02-24 (Monday)	289,331	USD 139,356,276	USD 139,356,276	0	USD -749,367	USD 481.65	USD 484.24
2025-02-21 (Friday)	289,331	USD 140,105,643	USD 140,105,643	0	USD 1,131,284	USD 484.24	USD 480.33
2025-02-20 (Thursday)	289,331	USD 138,974,359	USD 138,974,359	-236	USD 2,368,231	USD 480.33	USD 471.76
2025-02-19 (Wednesday)	289,567	USD 136,606,128	USD 136,606,128	-708	USD 2,467,148	USD 471.76	USD 462.11
2025-02-18 (Tuesday)	290,275	USD 134,138,980	USD 134,138,980	-354	USD 740,269	USD 462.11	USD 459
2025-02-17 (Monday)	290,629	USD 133,398,711	USD 133,398,711	0	USD 0	USD 459	USD 459
2025-02-14 (Friday)	290,629	USD 133,398,711	USD 133,398,711	0	USD -1,040,452	USD 459	USD 462.58
2025-02-13 (Thursday)	290,629	USD 134,439,163	USD 134,439,163	236	USD 2,833,055	USD 462.58	USD 453.2
2025-02-12 (Wednesday)	290,393	USD 131,606,108	USD 131,606,108	0	USD -586,593	USD 453.2	USD 455.22
2025-02-11 (Tuesday)	290,393	USD 132,192,701	USD 132,192,701	0	USD -4,283,297	USD 455.22	USD 469.97
2025-02-10 (Monday)	290,393	USD 136,475,998	USD 136,475,998	0	USD 188,755	USD 469.97	USD 469.32
2025-02-07 (Friday)	290,393	USD 136,287,243	USD 136,287,243	236	USD -3,324,699	USD 469.32	USD 481.16
2025-02-06 (Thursday)	290,157	USD 139,611,942	USD 139,611,942	0	USD -2,112,343	USD 481.16	USD 488.44
2025-02-05 (Wednesday)	290,157	USD 141,724,285	USD 141,724,285	0	USD 1,787,367	USD 488.44	USD 482.28
2025-02-04 (Tuesday)	290,157	USD 139,936,918	USD 139,936,918	0	USD 3,455,770	USD 482.28	USD 470.37
2025-02-03 (Monday)	290,157	USD 136,481,148	USD 136,481,148	0	USD 2,521,464	USD 470.37	USD 461.68
2025-01-31 (Friday)	290,157	USD 133,959,684	USD 133,959,684	0	USD 6,754,855	USD 461.68	USD 438.4
2025-01-30 (Thursday)	290,157	USD 127,204,829	USD 127,204,829	0	USD -905,290	USD 438.4	USD 441.52
2025-01-29 (Wednesday)	290,157	USD 128,110,119	USD 128,110,119	472	USD 451,733	USD 441.52	USD 440.68
2025-01-28 (Tuesday)	289,685	USD 127,658,386	USD 127,658,386	118	USD -874,614	USD 440.68	USD 443.88
2025-01-27 (Monday)	289,567	USD 128,533,000	USD 128,533,000	-11	USD 1,228,720	USD 443.88	USD 439.62
2025-01-24 (Friday)	289,578	USD 127,304,280	USD 127,304,280	354	USD 123,810	USD 439.62	USD 439.73
2025-01-23 (Thursday)	289,224	USD 127,180,470	USD 127,180,470	-4,956	USD 1,271,430	USD 439.73	USD 428
2025-01-22 (Wednesday)	294,180	USD 125,909,040	USD 125,909,040	343	USD 179,126	USD 428	USD 427.89
2025-01-21 (Tuesday)	293,837	USD 125,729,914	USD 125,729,914
2025-01-20 (Monday)	293,483	USD 123,849,826	USD 123,849,826
2025-01-17 (Friday)	293,483	USD 123,849,826	USD 123,849,826
2025-01-16 (Thursday)	293,129	USD 122,223,068	USD 122,223,068
2025-01-15 (Wednesday)	292,421	USD 124,062,533	USD 124,062,533
2025-01-14 (Tuesday)	292,421	USD 120,378,029	USD 120,378,029
2025-01-13 (Monday)	291,831	USD 120,634,180	USD 120,634,180
2025-01-10 (Friday)	291,831	USD 119,522,304	USD 119,522,304
2025-01-09 (Thursday)	291,584	USD 120,164,682	USD 120,164,682
2025-01-09 (Thursday)	291,584	USD 120,164,682	USD 120,164,682
2025-01-09 (Thursday)	291,584	USD 120,164,682	USD 120,164,682
2025-01-08 (Wednesday)	291,584	USD 120,164,682	USD 120,164,682
2025-01-08 (Wednesday)	291,584	USD 120,164,682	USD 120,164,682
2025-01-08 (Wednesday)	291,584	USD 120,164,682	USD 120,164,682
2025-01-02 (Thursday)	290,168	USD 117,738,568	USD 117,738,568
2024-12-30 (Monday)	289,932	USD 115,784,344	USD 115,784,344
2024-12-10 (Tuesday)	282,586	USD 132,595,003	USD 132,595,003	116	USD -1,290,128	USD 469.22	USD 473.98
2024-12-09 (Monday)	282,470	USD 133,885,131	USD 133,885,131	-812	USD 2,980,519	USD 473.98	USD 462.1
2024-12-06 (Friday)	283,282	USD 130,904,612	USD 130,904,612	464	USD 830,957	USD 462.1	USD 459.92
2024-12-05 (Thursday)	282,818	USD 130,073,655	USD 130,073,655	116	USD -1,094,419	USD 459.92	USD 463.98
2024-12-04 (Wednesday)	282,702	USD 131,168,074	USD 131,168,074	0	USD 1,981,741	USD 463.98	USD 456.97
2024-12-03 (Tuesday)	282,702	USD 129,186,333	USD 129,186,333	-464	USD -2,692,568	USD 456.97	USD 465.73
2024-12-02 (Monday)	283,166	USD 131,878,901	USD 131,878,901	232	USD -570,992	USD 465.73	USD 468.13
2024-11-29 (Friday)	282,934	USD 132,449,893	USD 132,449,893	342	USD 1,168,953	USD 468.13	USD 464.56
2024-11-28 (Thursday)	282,592	USD 131,280,940	USD 131,280,940	0	USD 0	USD 464.56	USD 464.56
2024-11-27 (Wednesday)	282,592	USD 131,280,940	USD 131,280,940	232	USD -600,945	USD 464.56	USD 467.07
2024-11-26 (Tuesday)	282,360	USD 131,881,885	USD 131,881,885	116	USD 1,567,008	USD 467.07	USD 461.71
2024-11-25 (Monday)	282,244	USD 130,314,877	USD 130,314,877	0	USD 3,031,300	USD 461.71	USD 450.97
2024-11-22 (Friday)	282,244	USD 127,283,577	USD 127,283,577	354	USD 328,778	USD 450.97	USD 450.37
2024-11-21 (Thursday)	281,890	USD 126,954,799	USD 126,954,799	116	USD -190,083	USD 450.37	USD 451.23
2024-11-20 (Wednesday)	281,774	USD 127,144,882	USD 127,144,882	0	USD 907,312	USD 451.23	USD 448.01
2024-11-19 (Tuesday)	281,774	USD 126,237,570	USD 126,237,570	348	USD -5,191,186	USD 448.01	USD 467.01
2024-11-18 (Monday)	281,426	USD 131,428,756	USD 131,428,756	-385	USD -6,658,634	USD 467.01	USD 490
2024-11-12 (Tuesday)	281,811	USD 138,087,390	USD 138,087,390	468	USD -3,068,020	USD 490	USD 501.72
2024-11-11 (Monday)	281,343	USD 141,155,410	USD 141,155,410	0	USD -4,225,772	USD 501.72	USD 516.74
2024-11-08 (Friday)	281,343	USD 145,381,182	USD 145,381,182	117	USD 4,079,178	USD 516.74	USD 502.45
2024-11-07 (Thursday)	281,226	USD 141,302,004	USD 141,302,004	2,925	USD 3,921,498	USD 502.45	USD 493.64
2024-11-06 (Wednesday)	278,301	USD 137,380,506	USD 137,380,506	351	USD -1,561,140	USD 493.64	USD 499.88
2024-11-05 (Tuesday)	277,950	USD 138,941,646	USD 138,941,646	117	USD 7,582,204	USD 499.88	USD 472.8
2024-11-04 (Monday)	277,833	USD 131,359,442	USD 131,359,442	234	USD 577,001	USD 472.8	USD 471.12
2024-11-01 (Friday)	277,599	USD 130,782,441	USD 130,782,441	0	USD -1,349,131	USD 471.12	USD 475.98
2024-10-31 (Thursday)	277,599	USD 132,131,572	USD 132,131,572	0	USD 249,839	USD 475.98	USD 475.08
2024-10-30 (Wednesday)	277,599	USD 131,881,733	USD 131,881,733	0	USD 1,310,267	USD 475.08	USD 470.36
2024-10-29 (Tuesday)	277,599	USD 130,571,466	USD 130,571,466	0	USD -1,668,370	USD 470.36	USD 476.37
2024-10-28 (Monday)	277,599	USD 132,239,836	USD 132,239,836	0	USD -369,206	USD 476.37	USD 477.7
2024-10-25 (Friday)	277,599	USD 132,609,042	USD 132,609,042	232	USD 1,716,781	USD 477.7	USD 471.91
2024-10-24 (Thursday)	277,367	USD 130,892,261	USD 130,892,261	-232	USD 406,851	USD 471.91	USD 470.05
2024-10-23 (Wednesday)	277,599	USD 130,485,410	USD 130,485,410	0	USD -1,349,131	USD 470.05	USD 474.91
2024-10-22 (Tuesday)	277,599	USD 131,834,541	USD 131,834,541	0	USD -882,765	USD 474.91	USD 478.09
2024-10-21 (Monday)	277,599	USD 132,717,306	USD 132,717,306	348	USD -1,194,927	USD 478.09	USD 483
2024-10-18 (Friday)	277,251	USD 133,912,233	USD 133,912,233

Share Trades of VRTX by Blackrock for IE00B53SZB19

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-04-16	BUY	236			485.890*		476.88
2025-04-15	BUY	590			500.490*		476.62
2025-04-14	BUY	1,416			495.830*		476.41
2025-04-11	BUY	472			484.220*		476.33
2025-04-09	BUY	1,298			482.300*		476.27
2025-04-08	BUY	2,360			472.370*		476.31
2025-04-04	SELL	-1,534			474.620*		476.35 Profit of 730,727 on sale
2025-04-02	SELL	-118			483.490*		476.27 Profit of 56,200 on sale
2025-04-01	SELL	-118			484.740*		476.17 Profit of 56,188 on sale
2025-03-31	SELL	-814			484.820*		476.06 Profit of 387,514 on sale
2025-03-26	BUY	1,050			500.280*		475.21
2025-03-25	BUY	1,292			509.040*		474.78
2025-03-24	BUY	354			511.740*		474.30
2025-03-21	BUY	118			503.200*		473.91
2025-03-20	BUY	236			510.180*		473.43
2025-03-19	BUY	926			512.520*		472.90
2025-03-18	BUY	236			512.230*		472.36
2025-03-17	SELL	-354			513.760*		471.79 Profit of 167,013 on sale
2025-03-14	BUY	590			504.770*		471.32
2025-03-13	BUY	236			502.920*		470.87
2025-03-11	SELL	-664			488.340*		470.26 Profit of 312,250 on sale
2025-03-10	SELL	-590			500.010*		469.81 Profit of 277,189 on sale
2025-03-06	SELL	-590			485.720*		469.28 Profit of 276,877 on sale
2025-03-05	SELL	-236			491.640*		468.93 Profit of 110,668 on sale
2025-03-04	SELL	-1,062			486.220*		468.66 Profit of 497,716 on sale
2025-03-03	SELL	-557			483.310*		468.42 Profit of 260,911 on sale
2025-02-28	SELL	-343			479.790*		468.24 Profit of 160,605 on sale
2025-02-25	SELL	-472			480.350*		467.73 Profit of 220,770 on sale
2025-02-20	SELL	-236			480.330*		466.95 Profit of 110,200 on sale
2025-02-19	SELL	-708			471.760*		466.86 Profit of 330,537 on sale
2025-02-18	SELL	-354			462.110*		466.95 Profit of 165,300 on sale
2025-02-13	BUY	236			462.580*		467.36
2025-02-07	BUY	236			469.320*		467.83
2025-01-29	BUY	472			441.520*		468.11
2025-01-28	BUY	118			440.680*		468.83
2025-01-27	SELL	-11			443.880*		469.50 Profit of 5,165 on sale
2025-01-24	BUY	354			439.620*		470.33
2025-01-23	SELL	-4,956			439.730*		471.21 Profit of 2,335,313 on sale
2025-01-22	BUY	343			428.000*		472.48
2024-12-10	BUY	116			469.220*		472.58
2024-12-09	SELL	-812			473.980*		472.54 Profit of 383,698 on sale
2024-12-06	BUY	464			462.100*		472.87
2024-12-05	BUY	116			459.920*		473.30
2024-12-03	SELL	-464			456.970*		474.22 Profit of 220,038 on sale
2024-12-02	BUY	232			465.730*		474.53
2024-11-29	BUY	342			468.130*		474.78
2024-11-27	BUY	232			464.560*		475.63
2024-11-26	BUY	116			467.070*		476.00
2024-11-22	BUY	354			450.970*		477.88
2024-11-21	BUY	116			450.370*		479.25
2024-11-19	BUY	348			448.010*		482.55
2024-11-18	SELL	-385			467.010*		483.46 Profit of 186,132 on sale
2024-11-12	BUY	468			490.000*		483.05
2024-11-08	BUY	117			516.740*		479.31
2024-11-07	BUY	2,925			502.450*		477.53
2024-11-06	BUY	351			493.640*		476.19
2024-11-05	BUY	117			499.880*		474.03
2024-11-04	BUY	234			472.800*		474.16
2024-10-25	BUY	232			477.700*		473.74
2024-10-24	SELL	-232			471.910*		474.35 Profit of 110,049 on sale
2024-10-21	BUY	348			478.090*		0.00

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VRTX

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer